Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Invesco Ltd. Director's Dealing 2018

Jan 18, 2018

10507_dirs_2018-01-18_3502df61-9e87-4039-b93d-806255a57dc2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Evofem Biosciences, Inc. (EVFM)
CIK: 0001618835
Period of Report: 2018-01-17

Reporting Person: Invesco Ltd. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common stock, Par value $0.0001 per share 7037498 Indirect

Footnotes

F1: Invesco Ltd. is the beneficial owner of 7,037,498 shares of common stock acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.

F2: Invesco Asset Management Ltd. is a subsidiary of Invesco Ltd., and it advises Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund

F3: As described in the Neothetics, Inc. Registration Statement on Form S-4 (File No. 333-221592), voting and investment power over the shares held by Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund is exercised by the directors of Invesco Asset Management Ltd. Neothetics, Inc. changed its name to Evofem Biosciences, Inc. on January 17, 2017.

F4: The common stock is directly owned by Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.